💥 We’re at a critical tipping point. AMR deaths could rise 70% by 2050.

On the last day of #WAAW2025, GARDP is flipping the R&D model and as Dr Manica notes in Mediaplanet, we need a shift in how we tackle & talk about antimicrobial resistance.

🔗 https://tinyurl.pulse.ly/pb09zirmta

#Thisisbig

🧬 The antibiotic pipeline is drying up, with only 90 antibiotics in development, and a small fraction addressing the most urgent threats.

In this video, Benjamin Blasco shares how we're acting now to uncover new innovative antibiotics and improve existing ones.

#WAAW2025 #AMR #Antibiotics

💡 AMR research faces a critical knowledge gap, fewer scientists entering the field and key lessons from antimicrobial R&D at risk of being lost.

Through REVIVE, GARDP is connecting researchers worldwide to bridge that gap and accelerate innovation.

#WAAW2025 #AMR #Antibiotics #ThisIsBig

🌍More than 50 million deaths could be prevented by 2050 if effective antibiotics were made accessible. Yet in many countries, they remain unavailable or unaffordable.

In this video, Abhijit Roy explains how we are acting now to close the access gap.

#WAAW2025 #AMR #Antibiotics

👶 Each year, 3M newborns globally are affected by sepsis, making it a leading cause of death in this age group.

GARDP’s landmark NeoSep1 trial is evaluating new antibiotic combinations to improve care for newborns with sepsis.

Watch Carol Ruffell share more this World Children’s Day.

#WAAW2025

🦠 Every day more than 1 million curable STIs are acquired. Drug-resistant gonorrhoea is spreading and treatment options are running out.

GARDP is acting now to change this. In this video, Yann Ferrisse explains how we are working on new solutions.

#WAAW2025 #AMR #Antibiotics #STIs

Serious bacterial infections cause 7.7M deaths every year.
Drug resistance is outpacing innovation, leaving few safe treatments.

François Franceschi explains how GARDP is acting now to change this.

#WAAW2025 #AMR #Antibiotics